Since CR has been proposed to serve as a putative target for MM therapy due to its essential role in MM cell lines [3], indirectly targeting CR through septin 7 and/or directly targeting septin 7 might represent yet another strategy for the development of a therapy to treat the currently incurable MM. This evidence concerns the gene CALB2 and Miyoshi myopathy.